We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACVA icon
976
ACV Auctions
ACVA
$1.27B
$178K 0.01%
+17,957
New +$230K
ACI icon
977
Albertsons Companies
ACI
$5.89B
$177K 0.01%
10,119
+530
+6% +$10.4K
PUBM icon
978
PubMatic
PUBM
$809M
$176K 0.01%
+21,268
New +$217K
ESPR
979
DELISTED
Esperion Therapeutics
ESPR
$173K 0.01%
65,327
-200,261
-75% -$387K
UEC icon
980
Uranium Energy
UEC
$5.63B
$172K 0.01%
12,905
-7,095
-35% -$71K
COTY icon
981
Coty
COTY
$2.51B
$171K 0.01%
42,407
+18,230
+75% +$83.5K
AVDL
982
DELISTED
Avadel Pharmaceuticals
AVDL
$170K 0.01%
11,164
-19,167
-63% -$249K
CAL icon
983
Caleres
CAL
$486M
$168K 0.01%
+12,917
New +$187K
CCO icon
984
Clear Channel Outdoor Holdings
CCO
$1.23B
$167K 0.01%
+105,504
New +$132K
IHS icon
985
IHS Holding
IHS
$2.79B
$167K 0.01%
24,428
-12,602
-34% -$84.3K
FLYW icon
986
Flywire
FLYW
$2.11B
$166K 0.01%
+12,252
New +$151K
WU icon
987
Western Union
WU
$2.19B
$164K 0.01%
20,480
+2,456
+14% +$20.5K
LIND icon
988
Lindblad Expeditions
LIND
$2.16B
$163K 0.01%
+12,700
New +$167K
FTRE icon
989
Fortrea Holdings
FTRE
$1.81B
$162K 0.01%
+19,200
New +$147K
WRD
990
WeRide Inc
WRD
$2.08B
$161K 0.01%
+16,230
New +$154K
PRAA icon
991
PRA Group
PRAA
$714M
$160K 0.01%
+10,395
New +$168K
BBAI icon
992
BigBear.ai
BBAI
$1.55B
$160K 0.01%
+24,514
New +$157K
SHC icon
993
Sotera Health
SHC
$5.41B
$158K 0.01%
+10,060
New +$141K
BRR
994
ProCap Financial Inc
BRR
$154M
$156K 0.01%
+15,378
New +$158K
PGRE
995
DELISTED
Paramount Group
PGRE
$155K 0.01%
+23,750
New +$158K
KC
996
Kingsoft Cloud Holdings
KC
$3.58B
$153K 0.01%
10,268
-8,910
-46% -$129K
AOUT icon
997
American Outdoor Brands
AOUT
$160M
$150K 0.01%
17,317
+755
+5% +$7.15K
TRDA icon
998
Entrada Therapeutics
TRDA
$271M
$149K 0.01%
+25,754
New +$151K
OSG
999
Octave Specialty Group
OSG
$210M
$149K 0.01%
+17,878
New +$151K
ZVRA icon
1000
Zevra Therapeutics
ZVRA
$682M
$148K 0.01%
+15,600
New +$156K
38 39
40
41 42

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.